17-Aug-2022 | Facts and Factors
According to Facts and Factors, the global telehealth for women's reproductive and sexual health market size was worth around USD 92.50 million in 2021 and is estimated to grow to about USD 227.70 million by 2028, with a compound annual growth rate (CAGR) of approximately 16.20% over the forecast period. The report analyzes the telehealth for women reproductive and sexual health market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in telehealth for the women's reproductive and sexual health market.
Telemedicine is defined by the World Health Organization (WHO) as the delivery of medical services by medical professionals while leveraging technology to share data for the purpose of disease diagnosis, treatment, and prevention. The use of telemedicine in reproductive health care has shown potential in providing creative solutions to unmet health needs, particularly in regions with few health care professionals, even though it has not yet been widely implemented throughout the U.S. Leading medical organizations support the use of telemedicine to improve access for rural women and strengthen reproductive health services.Basic communication methods such as phone calls, texts, emails, faxes, and online patient health portals can be a part of telemedicine. These technologies let patients schedule appointments, read appointment summaries, examine lab results, and engage with their doctors.
Browse the full “Telehealth for Women's Reproductive and Sexual Health Market Size, Share, Growth Analysis Report By Age Group(Adolescent, Adult, and Geriatric), By Offering (Consulting Services, Diagnostic/Testing Services, and Drug Delivery), By Application (Birth Control, STD Prevention, Menopause, PMS, Postpartum Depression, Pelvic Pain, Urinary Tract Infection (UTI), Incontinence, Endometriosis, Vulvodynia, and Others), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028" report at https://www.fnfresearch.com/telehealth-for-womens-reproductive-and-sexual-health-market
Due to unequal access to technology, many settings find it challenging or impossible to integrate innovative digital health care delivery options. Telehealth is a more affordable option than traditional treatment. Virtual healthcare services are becoming more popular as smartphone use and dependence rise. Due to its many uses, telemedicine has long been hailed as a way to improve access to healthcare, particularly in rural areas with a shortage of clinicians.Adoption of smartphones, acceptance of preventative healthcare, supportive legislation, and increased funding are all factors promoting market expansion and awareness in an effort to address the lowered availability of clinic-based services during the pandemic while keeping an eye on the obstacles to digital health solutions.
Segmental Overview
The telehealth for women reproductive and sexual health market is segregated based onage group, by offering, by application.By age group, the market is divided into adolescents, adults and Geriatric. Adults dominate in this particular segment in 2021. By offering, the market is divided into consulting services, diagnostic/testing services, and drug delivery. In this segment, in 2021, consulting services held a dominant share, but drug delivery is also gaining traction. By Application, the market is divided into birth control, STD prevention, menopause, pms, postpartum depression, pelvic pain, urinary tract infection (uti), incontinence, endometriosis, vulvodynia, and others. In 2021, the majority of women use these services for birth control in this segment.
Regional Overview
Over the anticipated time frame, North America will profitably add to the value of the worldwide market. The expansion of the regional market is dependent on the substantial participation of significant players in nations like the U.S. Regional market trends will also be influenced by advantageous remuneration practices and a high level of adoption of new telehealth for women's reproductive and sexual health services. The market for telehealth for women's reproductive and sexual health market in North America is expected to experience exponential expansion over the coming years as a result of regional governments imposing harsh laws pertaining to drug misuse. Developing countries in Asia-Pacific are growing at a very fast rate.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 92.50 Million |
Projected Market Size in 2028 |
USD 227.71 Million |
CAGR Growth Rate |
16.20% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
American Well, HeyDoctor, LLC, Maven Clinic Co, ICEBREAKER HEALTH INC. (Lemonaid), NURX Inc., Pandia Health, Inc., PILL CLUB, and Others |
Key Segment |
By Age Group, Offering, Application, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Competitive Landscape
Key players functioning in the telehealth for women reproductive and sexual health marketAmerican Well, HeyDoctor, LLC, Maven Clinic Co, ICEBREAKER HEALTH INC. (Lemonaid), NURX Inc., Pandia Health, Inc., PILL CLUB, amongst others.
Recent developments:
- Nurx collaborated with Ovia Health, the only digital family health platform with clinical support. A new birth control tracking tool will be added to the Ovia Fertility mobile app as a result of this collaboration between the two businesses. To help women stay on top of their preferred method of birth control, the new capability enables users to track the combination pill, the minipill, the extended cycle pill, and the intrauterine device.
Global Telehealth for women's reproductive and Sexual Health market is segmented as follows:
By Age Group
- Adolescent
- Adult
- Geriatric
By Offering
- Consulting Services
- Diagnostic/Testing Services
- Drug Delivery
By Application
- Birth Control
- STD Prevention
- Menopause
- PMS
- Postpartum Depression
- Pelvic Pain
- Urinary Tract Infection (UTI)
- Incontinence
- Endometriosis
- Vulvodynia
- Others
By Region
-
North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
